A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

JN Cohn, G Tognoni - New England Journal of Medicine, 2001 - Mass Medical Soc
Background Actions of angiotensin II may contribute to the progression of heart failure
despite treatment with currently recommended drugs. We therefore evaluated the long-term …

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

JN Cohn, G Tognoni… - The New England …, 2001 - pubmed.ncbi.nlm.nih.gov
Background Actions of angiotensin II may contribute to the progression of heart failure
despite treatment with currently recommended drugs. We therefore evaluated the long-term …

[引用][C] A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

JN COHN, G TOGNONI - The New England journal of …, 2001 - pascal-francis.inist.fr
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

JN Cohn, G Tognoni - The New England Journal of Medicine, 2001 - europepmc.org
Background Actions of angiotensin II may contribute to the progression of heart failure
despite treatment with currently recommended drugs. We therefore evaluated the long-term …

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

JN Cohn, G Tognoni - New England Journal of Medicine, 2001 - experts.umn.edu
Background: Actions of angiotensin II may contribute to the progression of heart failure
despite treatment with currently recommended drugs. We therefore evaluated the long-term …

[引用][C] A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

JN COHN, G TOGNONI - The New England …, 2001 - Massachusetts Medical Society